nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Malaise—Etoposide—uterine cancer	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Face oedema—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Vertigo—Etoposide—uterine cancer	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Abdominal pain—Dactinomycin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Body temperature increased—Dactinomycin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Hypoglycaemia—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Loss of consciousness—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Cough—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Convulsion—Etoposide—uterine cancer	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Hyponatraemia—Doxorubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Hypertension—Etoposide—uterine cancer	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Diplopia—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Dry skin—Epirubicin—uterine cancer	0.001	0.001	CcSEcCtD
Gadoversetamide—Chest pain—Etoposide—uterine cancer	0.001	0.001	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000994	0.000994	CcSEcCtD
Gadoversetamide—Discomfort—Etoposide—uterine cancer	0.000989	0.000989	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Epirubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Gadoversetamide—Face oedema—Doxorubicin—uterine cancer	0.000978	0.000978	CcSEcCtD
Gadoversetamide—Hypersensitivity—Dactinomycin—uterine cancer	0.000977	0.000977	CcSEcCtD
Gadoversetamide—Confusional state—Etoposide—uterine cancer	0.000968	0.000968	CcSEcCtD
Gadoversetamide—Muscular weakness—Epirubicin—uterine cancer	0.000965	0.000965	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000965	0.000965	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Etoposide—uterine cancer	0.00096	0.00096	CcSEcCtD
Gadoversetamide—Asthenia—Dactinomycin—uterine cancer	0.000952	0.000952	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Doxorubicin—uterine cancer	0.000949	0.000949	CcSEcCtD
Gadoversetamide—Asthma—Epirubicin—uterine cancer	0.000946	0.000946	CcSEcCtD
Gadoversetamide—Dysphagia—Epirubicin—uterine cancer	0.000946	0.000946	CcSEcCtD
Gadoversetamide—Influenza—Epirubicin—uterine cancer	0.000946	0.000946	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Etoposide—uterine cancer	0.00094	0.00094	CcSEcCtD
Gadoversetamide—Tachycardia—Etoposide—uterine cancer	0.000937	0.000937	CcSEcCtD
Gadoversetamide—Skin disorder—Etoposide—uterine cancer	0.000932	0.000932	CcSEcCtD
Gadoversetamide—Dry skin—Doxorubicin—uterine cancer	0.000928	0.000928	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Etoposide—uterine cancer	0.000928	0.000928	CcSEcCtD
Gadoversetamide—Anorexia—Etoposide—uterine cancer	0.000915	0.000915	CcSEcCtD
Gadoversetamide—Diarrhoea—Dactinomycin—uterine cancer	0.000907	0.000907	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Doxorubicin—uterine cancer	0.000906	0.000906	CcSEcCtD
Gadoversetamide—Hypotension—Etoposide—uterine cancer	0.000897	0.000897	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000893	0.000893	CcSEcCtD
Gadoversetamide—Muscular weakness—Doxorubicin—uterine cancer	0.000893	0.000893	CcSEcCtD
Gadoversetamide—Dysuria—Epirubicin—uterine cancer	0.000885	0.000885	CcSEcCtD
Gadoversetamide—Asthma—Doxorubicin—uterine cancer	0.000875	0.000875	CcSEcCtD
Gadoversetamide—Dysphagia—Doxorubicin—uterine cancer	0.000875	0.000875	CcSEcCtD
Gadoversetamide—Influenza—Doxorubicin—uterine cancer	0.000875	0.000875	CcSEcCtD
Gadoversetamide—Paraesthesia—Etoposide—uterine cancer	0.000862	0.000862	CcSEcCtD
Gadoversetamide—Dyspnoea—Etoposide—uterine cancer	0.000856	0.000856	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Epirubicin—uterine cancer	0.000853	0.000853	CcSEcCtD
Gadoversetamide—Somnolence—Etoposide—uterine cancer	0.000853	0.000853	CcSEcCtD
Gadoversetamide—Pneumonia—Epirubicin—uterine cancer	0.000849	0.000849	CcSEcCtD
Gadoversetamide—Vomiting—Dactinomycin—uterine cancer	0.000843	0.000843	CcSEcCtD
Gadoversetamide—Rash—Dactinomycin—uterine cancer	0.000836	0.000836	CcSEcCtD
Gadoversetamide—Decreased appetite—Etoposide—uterine cancer	0.000834	0.000834	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000829	0.000829	CcSEcCtD
Gadoversetamide—Fatigue—Etoposide—uterine cancer	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Constipation—Etoposide—uterine cancer	0.000821	0.000821	CcSEcCtD
Gadoversetamide—Pain—Etoposide—uterine cancer	0.000821	0.000821	CcSEcCtD
Gadoversetamide—Urinary tract infection—Epirubicin—uterine cancer	0.00082	0.00082	CcSEcCtD
Gadoversetamide—Conjunctivitis—Epirubicin—uterine cancer	0.00082	0.00082	CcSEcCtD
Gadoversetamide—Dysuria—Doxorubicin—uterine cancer	0.000819	0.000819	CcSEcCtD
Gadoversetamide—Haematuria—Epirubicin—uterine cancer	0.000804	0.000804	CcSEcCtD
Gadoversetamide—Epistaxis—Epirubicin—uterine cancer	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Sinusitis—Epirubicin—uterine cancer	0.000791	0.000791	CcSEcCtD
Gadoversetamide—Feeling abnormal—Etoposide—uterine cancer	0.000791	0.000791	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00079	0.00079	CcSEcCtD
Gadoversetamide—Nausea—Dactinomycin—uterine cancer	0.000788	0.000788	CcSEcCtD
Gadoversetamide—Pneumonia—Doxorubicin—uterine cancer	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Etoposide—uterine cancer	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Urticaria—Etoposide—uterine cancer	0.000763	0.000763	CcSEcCtD
Gadoversetamide—Haemoglobin—Epirubicin—uterine cancer	0.000761	0.000761	CcSEcCtD
Gadoversetamide—Rhinitis—Epirubicin—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Abdominal pain—Etoposide—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Body temperature increased—Etoposide—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Urinary tract infection—Doxorubicin—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Conjunctivitis—Doxorubicin—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadoversetamide—Haemorrhage—Epirubicin—uterine cancer	0.000757	0.000757	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Epirubicin—uterine cancer	0.000754	0.000754	CcSEcCtD
Gadoversetamide—Pharyngitis—Epirubicin—uterine cancer	0.000752	0.000752	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Epirubicin—uterine cancer	0.000748	0.000748	CcSEcCtD
Gadoversetamide—Oedema peripheral—Epirubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
Gadoversetamide—Haematuria—Doxorubicin—uterine cancer	0.000744	0.000744	CcSEcCtD
Gadoversetamide—Urethral disorder—Epirubicin—uterine cancer	0.000742	0.000742	CcSEcCtD
Gadoversetamide—Epistaxis—Doxorubicin—uterine cancer	0.000736	0.000736	CcSEcCtD
Gadoversetamide—Sinusitis—Doxorubicin—uterine cancer	0.000732	0.000732	CcSEcCtD
Gadoversetamide—Erythema multiforme—Epirubicin—uterine cancer	0.000716	0.000716	CcSEcCtD
Gadoversetamide—Eye disorder—Epirubicin—uterine cancer	0.000708	0.000708	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—uterine cancer	0.000707	0.000707	CcSEcCtD
Gadoversetamide—Tinnitus—Epirubicin—uterine cancer	0.000706	0.000706	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—uterine cancer	0.000704	0.000704	CcSEcCtD
Gadoversetamide—Flushing—Epirubicin—uterine cancer	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Cardiac disorder—Epirubicin—uterine cancer	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—uterine cancer	0.000703	0.000703	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—uterine cancer	0.000701	0.000701	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—uterine cancer	0.000697	0.000697	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—uterine cancer	0.000695	0.000695	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000692	0.000692	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—uterine cancer	0.00069	0.00069	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—uterine cancer	0.000689	0.000689	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—uterine cancer	0.000687	0.000687	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—uterine cancer	0.000687	0.000687	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—uterine cancer	0.000684	0.000684	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—uterine cancer	0.000683	0.000683	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—uterine cancer	0.00068	0.00068	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—uterine cancer	0.000679	0.000679	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—uterine cancer	0.000677	0.000677	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—uterine cancer	0.000663	0.000663	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—uterine cancer	0.000663	0.000663	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—uterine cancer	0.000659	0.000659	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—uterine cancer	0.000659	0.000659	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—uterine cancer	0.000657	0.000657	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—uterine cancer	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—uterine cancer	0.000653	0.000653	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—uterine cancer	0.000647	0.000647	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—uterine cancer	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—uterine cancer	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—uterine cancer	0.000638	0.000638	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—uterine cancer	0.000636	0.000636	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—uterine cancer	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—uterine cancer	0.000634	0.000634	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—uterine cancer	0.000633	0.000633	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—uterine cancer	0.000632	0.000632	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—uterine cancer	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—uterine cancer	0.000626	0.000626	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—uterine cancer	0.000621	0.000621	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000612	0.000612	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—uterine cancer	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—uterine cancer	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—uterine cancer	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—uterine cancer	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Rash—Etoposide—uterine cancer	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—uterine cancer	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Headache—Etoposide—uterine cancer	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—uterine cancer	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—uterine cancer	0.000599	0.000599	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—uterine cancer	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—uterine cancer	0.000595	0.000595	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—uterine cancer	0.000592	0.000592	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—uterine cancer	0.000592	0.000592	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—uterine cancer	0.000591	0.000591	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—uterine cancer	0.00059	0.00059	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—uterine cancer	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—uterine cancer	0.000583	0.000583	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—uterine cancer	0.000579	0.000579	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—uterine cancer	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—uterine cancer	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—uterine cancer	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—uterine cancer	0.00057	0.00057	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—uterine cancer	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000566	0.000566	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—uterine cancer	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000557	0.000557	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—uterine cancer	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—uterine cancer	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—uterine cancer	0.000549	0.000549	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—uterine cancer	0.000548	0.000548	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—uterine cancer	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—uterine cancer	0.000543	0.000543	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—uterine cancer	0.000539	0.000539	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—uterine cancer	0.000538	0.000538	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—uterine cancer	0.000538	0.000538	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—uterine cancer	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—uterine cancer	0.000532	0.000532	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—uterine cancer	0.000528	0.000528	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000527	0.000527	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—uterine cancer	0.000527	0.000527	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—uterine cancer	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—uterine cancer	0.00052	0.00052	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—uterine cancer	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—uterine cancer	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—uterine cancer	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—uterine cancer	0.000518	0.000518	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—uterine cancer	0.000513	0.000513	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—uterine cancer	0.000513	0.000513	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—uterine cancer	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—uterine cancer	0.000503	0.000503	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—uterine cancer	0.000502	0.000502	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000498	0.000498	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—uterine cancer	0.000498	0.000498	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00049	0.00049	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—uterine cancer	0.00049	0.00049	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—uterine cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—uterine cancer	0.000486	0.000486	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—uterine cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—uterine cancer	0.000483	0.000483	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—uterine cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—uterine cancer	0.000475	0.000475	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—uterine cancer	0.000474	0.000474	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—uterine cancer	0.000468	0.000468	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—uterine cancer	0.000464	0.000464	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—uterine cancer	0.00046	0.00046	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—uterine cancer	0.00046	0.00046	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—uterine cancer	0.00045	0.00045	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—uterine cancer	0.000447	0.000447	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—uterine cancer	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—uterine cancer	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—uterine cancer	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—uterine cancer	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—uterine cancer	0.000438	0.000438	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—uterine cancer	0.000433	0.000433	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00043	0.00043	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—uterine cancer	0.000429	0.000429	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—uterine cancer	0.000427	0.000427	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—uterine cancer	0.000426	0.000426	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—uterine cancer	0.000426	0.000426	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—uterine cancer	0.00041	0.00041	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000407	0.000407	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—uterine cancer	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—uterine cancer	0.000395	0.000395	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—uterine cancer	0.000394	0.000394	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—uterine cancer	0.000394	0.000394	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—uterine cancer	0.000386	0.000386	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—uterine cancer	0.000381	0.000381	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—uterine cancer	0.000368	0.000368	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—uterine cancer	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—uterine cancer	0.000356	0.000356	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—uterine cancer	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—uterine cancer	0.000342	0.000342	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—uterine cancer	0.000341	0.000341	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—uterine cancer	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—uterine cancer	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—uterine cancer	0.000337	0.000337	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—uterine cancer	0.000329	0.000329	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—uterine cancer	0.00032	0.00032	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—uterine cancer	0.000317	0.000317	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—uterine cancer	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—uterine cancer	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—uterine cancer	0.000312	0.000312	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—uterine cancer	0.000296	0.000296	CcSEcCtD
